The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

TXG) on Tuesday reported a loss of $35.8 million in its third quarter. On a per-share basis, the Pleasanton, California-based company said it had a loss of 30 cents. The results topped Wall Street ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).

Genomics (TXG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Ryskin from ...

The company beat consensus EPS estimates in each ... Should You Invest in 10x Genomics (TXG)? Before you invest in 10x Genomics (TXG), want to know the best stocks to buy for the next 30 days?

The market expects 10x Genomics (TXG) to deliver a year-over-year increase ... This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor ...